I2o Therapeutics has a total of 63 patents globally, out of which 1 has been granted. Of these 63 patents, more than 98% patents are active. Europe is where I2o Therapeutics has filed the maximum number of patents, followed by China, Mexico, Australia and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of I2o Therapeutics.
I2o Therapeutics was founded in 2019. I2o Therapeutics is a biotech enterprise. The business creates a platform for biological medications that are typically administered via injection. The goal of I2o Therapeutics is to develop protein- and peptide-based oral medicines. Customers in the US are served by I2o Therapeutics.
Do read about some of the most popular patents of I2o Therapeutics which have been covered by us in this article and also you can find I2o Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over I2o Therapeutics patent portfolio.
How many patents does I2o Therapeutics have?
I2o Therapeutics has a total of 63 patents globally. These patents belong to 12 unique patent families. Out of 63 patents, 62 patents are active.
How Many Patents did I2o Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | I2o Therapeutics Applications Filed | I2o Therapeutics Patents Granted |
| 2023 | 9 | 1 |
| 2022 | 10 | – |
| 2021 | 39 | – |
| 2018 | 2 | – |
| 2017 | 1 | – |
| 2016 | 1 | – |
How many I2o Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did I2o Therapeutics File in Different Countries?
Countries in which I2o Therapeutics Filed Patents
| Country | Patent |
| Europe | 10 |
| Australia | 5 |
| Singapore | 5 |
| Mexico | 5 |
| China | 5 |
| Canada | 5 |
| South Africa | 5 |
| Israel | 5 |
| New Zealand | 4 |
| Brazil | 4 |
| Hong Kong (S.A.R.) | 3 |
| India | 2 |
| United States of America | 2 |
Where are Research Centers of I2o Therapeutics Patents Located?
The Research Center for I2o Therapeutics is the United States of America.
Best I2o Therapeutics Patent
EP3733694A1 is the most popular patent in the I2o Therapeutics portfolio. It has received 20 citations so far from companies like Intarcia Therapeutics, Eli Lilly and Zhejiang Heze Pharmaceutical Technology.
What are I2o Therapeutics key innovation segments?
What Technologies are Covered by I2o Therapeutics?
The chart below distributes patents filed by I2o Therapeutics